AMY HUSTON: Open Payments
NPI 1306077946 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 17 payments from 10 companies in 2025. Trend: 2023 $410 · 2024 $548 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $122 |
| Novo Nordisk Inc | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| PFIZER INC. | 1 | $34 |
| Exact Sciences Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: VRAYLAR, PREVNAR 20, Cologuard Collection Kit, Wegovy, MOUNJARO, Fluad, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across TX — which companies pay providers there.
